CBS 2019
CBSMD教育中心
中 文

Acute Coronary Syndrom

Abstract

Recommended Article

Effect of Medication Co-payment Vouchers on P2Y12 Inhibitor Use and Major Adverse Cardiovascular Events Among Patients With Myocardial Infarction: The ARTEMIS Randomized Clinical Trial Risk Stratification for Patients in Cardiogenic Shock After Acute Myocardial Infarction Invasive Versus Medical Management in Patients With Prior Coronary Artery Bypass Surgery With a Non-ST Segment Elevation Acute Coronary Syndrome: A Pilot Randomized Controlled Trial Acute Noncardiac Organ Failure in Acute Myocardial Infarction With Cardiogenic Shock Long-term outcomes after myocardial infarction in middle-aged and older patients with congenital heart disease-a nationwide study Effect of alirocumab on major adverse cardiovascular events according to renal function in patients with a recent acute coronary syndrome: prespecified analysis from the ODYSSEY OUTCOMES randomized clinical trial Spontaneous Coronary Artery Dissection: Current State of the Science: A Scientific Statement From the American Heart Association BMI, Infarct Size, and Clinical Outcomes Following Primary PCI Patient-Level Analysis From 6 Randomized Trials

Editorial2019 Apr 22;12(8):731-733.

JOURNAL:JACC Cardiovasc Interv. Article Link

Treating Multivessel Coronary Artery Disease in ST-Segment Elevation Myocardial Infarction: Why, How, and When?

Berry C, Collison D, Mangion K. Keywords: ST-segment elevation myocardial infarction; fractional flow reserve; multivessel disease; percutaneous coronary intervention; remodeling

LINK

Please click on "Article Link" to get further access to this Editorial.